A Randomized, Double-blind, Placebo-controlled, Dose-ranging, Parallel-group, Multicenter, Safety and Efficacy Trial of Zafirlukast (ACCOLATE) in the Treatment of Pediatric Patients with Mild-to-moderate Asthma; up to a 52-week Open-label Safety Extension (9188IL/0079). Report for the Open-label Extension only.

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].

*Please Note* The Study information you are attempting to view is not available on ClinicalTrials.gov as the Study predates the Food and Drug Administration Amendments Act (FDAAA), Section 801 requirements. More information regarding this study may be available by contacting [email protected].